Skip to content

CASI PHARMACEUTICALS, INC.

CASIF

CIK 0001962738

← back to feed
Revenue (TTM)
$28.54M
−15.8% YoY FY Dec 2025
Net Income (TTM)
−$48.06M
−22.4% YoY FY Dec 2025
EPS Diluted (TTM)
−$2.59
−1.2% YoY FY Dec 2025
Gross Margin
35.3%
FY Dec 2025
Operating Margin
-157.7%
FY Dec 2025
Net Margin
-168.4%
FY Dec 2025
Free Cash Flow (TTM)
−$20.77M
FY Dec 2025
Cash
$5.63M
FY Dec 2025
Total Debt
$38.09M
FY Dec 2025
Shares Outstanding
20.56M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings